ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,628Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 3593

$1.38M Total Retail Price of All Prescriptions

Rank: 65 out of 3593

617 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 617 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 23,684 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,039 945 1 5
LISINOPRIL 714 648 2 2
SIMVASTATIN 675 643 3 1
AMLODIPINE BESYLATE 663 623 4 3
LEVOTHYROXINE SODIUM 454 399 5 4
DONEPEZIL HCL 442 442 6 31
ATENOLOL 423 395 7 11
FUROSEMIDE 387 361 8 9
IBUPROFEN 374 319 9 43
METFORMIN HCL 373 318 10 6
METOPROLOL TARTRATE 369 340 11 8
SURE COMFORT 365 355 10 12 159
NEXIUM 355 313 13 36
HYDROCHLOROTHIAZIDE 354 327 14 10
VOLTAREN 347 327 15 85
CLOPIDOGREL 340 312 16 30
LACTULOSE 336 323 17 126
ALENDRONATE SODIUM 332 328 18 22
NAMENDA 330 330 19 50
ZOLPIDEM TARTRATE 324 312 20 12
POTASSIUM CHLORIDE 322 314 21 24
SILVER SULFADIAZINE 300 299 10 22 248
NOVOLIN 70-30 289 266 23 146
BUMETANIDE 256 253 24 148
INSULIN SYRINGE 249 208 25 91
RANITIDINE HCL 248 231 26 27
LOVAZA 247 242 27 106
ADVAIR DISKUS 236 207 28 47
DIOVAN 229 211 29 46
CRESTOR 229 205 29 21
METOPROLOL SUCCINATE 225 195 31 19
PLAVIX 224 214 32 42
LIDODERM 213 196 33 78
BETAMETHASONE DIPROPIONATE 209 209 34 305
PENTOXIFYLLINE 204 204 35 149
TRIAMCINOLONE ACETONIDE 203 191 36 119
GABAPENTIN 201 158 37 16
GLIMEPIRIDE 199 197 38 44
TRAMADOL HCL 199 183 38 17
NAPROXEN 197 179 40 68
ISOSORBIDE MONONITRATE ER 187 187 41 61
WARFARIN SODIUM 185 184 42 18
LANTUS 183 166 43 57
NOVOLIN R 179 154 44 140
DICLOFENAC SODIUM 179 179 44 74
MEGESTROL ACETATE 174 169 R 46 152
SINGULAIR 173 144 47 77
KETOCONAZOLE 171 156 48 118
CARVEDILOL 166 148 49 23
QUETIAPINE FUMARATE 161 161 50 89
ALLOPURINOL 160 155 51 35
NYSTATIN 153 150 52 167
AZITHROMYCIN 148 135 53 34
ESCITALOPRAM OXALATE 146 130 54 71
ATORVASTATIN CALCIUM 141 139 55 15
SSD 138 130 56 348
LEVEMIR 136 133 57 193
CLONIDINE HCL 132 127 58 41
AMLODIPINE BESYLATE-BENAZEPRIL 132 111 58 65
ENALAPRIL MALEATE 131 114 60 38
TRIAMTERENE-HCTZ 129 129 61 66
PROCTOZONE-HC 123 120 62 209
DIGOXIN 122 121 63 58
GLIPIZIDE 121 112 64 40
CITALOPRAM HBR 121 104 64 25
PROAIR HFA 115 94 66 54
TRAMADOL HCL-ACETAMINOPHEN 111 99 67 147
CARBIDOPA-LEVODOPA 111 111 67 135
PANTOPRAZOLE SODIUM 110 95 69 45
MUPIROCIN 110 110 69 132
LOVASTATIN 109 99 71 20
CILOSTAZOL 109 97 71 163
FLUTICASONE PROPIONATE 107 101 73 32
LOSARTAN POTASSIUM 107 91 73 14
CIPROFLOXACIN HCL 105 102 75 52
MONTELUKAST SODIUM 104 82 76 151
SEROQUEL 103 103 77 172
NIFEDIPINE ER 100 94 78 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 97 93 79 102
LOPERAMIDE 96 79 80 277
NITROGLYCERIN PATCH 93 93 81 212
METHOCARBAMOL 91 84 R 82 185
MECLIZINE HCL 90 88 83 96
CLOBETASOL PROPIONATE 88 84 84 187
FAMOTIDINE 87 73 85 70
LEXAPRO 85 85 86 184
LYRICA 83 68 87 105
EXELON 82 79 88 123
SPIRONOLACTONE 78 78 89 86
CLOTRIMAZOLE-BETAMETHASONE 76 72 90 94
GLYBURIDE-METFORMIN HCL 76 57 R 90 95
AMMONIUM LACTATE 74 67 92 125
TAMSULOSIN HCL 70 66 93 33
GEMFIBROZIL 70 53 93 88
NATEGLINIDE 69 67 95 345
DIOVAN HCT 68 58 96 76
CLOTRIMAZOLE 67 64 97 319
HUMULIN 70-30 66 65 98 215
PAROXETINE HCL 66 54 98 62
SERTRALINE HCL 65 56 100 28
SPIRIVA 64 62 101 87
RISPERIDONE 64 61 101 83
COMBIVENT 63 60 103 161
TRAZODONE HCL 62 56 104 53
FLUOXETINE HCL 62 62 104 60
ACETAMINOPHEN-CODEINE 60 55 S3 106 153
FEXOFENADINE HCL 59 51 107 469
NEOMYCIN-POLYMYXIN-HYDROCORT 58 52 108 463
PRAVASTATIN SODIUM 58 46 108 13
VENTOLIN HFA 57 56 110 80
NOVOLOG 57 57 110 134
LEVETIRACETAM 55 55 112 127
NASONEX 55 50 112 192
THERMAZENE 54 53 114 450
DOXAZOSIN MESYLATE 54 52 114 63
CHOLESTYRAMINE 53 43 116 386
GLYBURIDE 53 51 R 116 55
SYNTHROID 52 40 118 51
PATANOL 52 52 118 425
GENTAMICIN SULFATE 52 43 118 318
ZETIA 51 51 121 110
SUCRALFATE 51 43 121 237
CYMBALTA 50 46 123 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.